Specipig opens neonatal intensive care unit

2022.09.06
News

Specipig has opened a neonatal intensive care unit (NICU) at its research facilities in the Barcelona area to continue responding to the rising global demand* for preclinical Contract Research Organization (CRO) services.

The new NICU is equipped with specific equipment, such as incubators, dosing pumps, temperature and oxygen control systems. Specipig is also expertise in new-born, preterm and maternity related research preclinical studies with adapted facilities for these projects.

With a highly qualified team of over 20 professionals and a network of experts in human and veterinary medicine and surgery, since 2013, Specipig has been providing support for R&D biomedical research projects, preclinical testing and regulatory preclinical trials across numerous therapeutic areas including neonatal, cardiovascular, abdominal, respiratory, ophthalmology, dermatology, urology, neurology and dental.

Specipig is also expertise in new-born, preterm and maternity related research preclinical studies

“In recent years we have seen an increase in the need of preclinical CRO services among academic institutions and pharmaceutical, biotech and medtech companies that are looking for expertise in this strategic phase of medical device and drug development to achieve a successful launch to market. Specipig now offers preclinical CRO services in Europe and world-wide with GLP certification,” explains Specipig Business Development Manager Assela Bosch.

This September, Specipig will attend the international events MedFit 2022 in Grenoble (France) and NLSDays 2022 in Malmö (Sweden) to present the new NICU and its services in one-to-one meetings with the life sciences industry.

Please contact us if you are interested to learn more about this service.

* The global preclinical CRO market size was valued at USD 4.87 billion in 2021 and is expected to advance at a compound annual growth rate of 7.9% from 2022 to 2030 (source: Grand View Research Report).